Fazli L - Search Results

1

Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality.

Tse BWC, Volpert M, Ratther E, Stylianou N, Nouri M, McGowan K, Lehman ML, McPherson SJ, Roshan-Moniri M, Butler MS, Caradec J, Gregory-Evans CY, McGovern J, Das R, Takhar M, Erho N, Alshalafa M, Davicioni E, Schaeffer EM, Jenkins RB, Ross AE, Karnes RJ, Den RB, Fazli L, Gregory PA, Gleave ME, Williams ED, Rennie PS, Buttyan R, Gunter JH, Selth LA, Russell PJ, Nelson CC, Hollier BG. Tse BWC, et al. Among authors: fazli l. Oncogene. 2017 Jun 15;36(24):3417-3427. doi: 10.1038/onc.2016.482. Epub 2017 Jan 16. Oncogene. 2017. PMID: 28092670 Free PMC article.

2

The role of DAB2IP in androgen receptor activation during prostate cancer progression.

Wu K, Liu J, Tseng SF, Gore C, Ning Z, Sharifi N, Fazli L, Gleave M, Kapur P, Xiao G, Sun X, Oz OK, Min W, Alexandrakis G, Yang CR, Hsieh CL, Wu HC, He D, Xie D, Hsieh JT. Wu K, et al. Among authors: fazli l. Oncogene. 2014 Apr 10;33(15):1954-63. doi: 10.1038/onc.2013.143. Epub 2013 Apr 22. Oncogene. 2014. PMID: 23604126

3

Regulation of c-Myc expression by the histone demethylase JMJD1A is essential for prostate cancer cell growth and survival.

Fan L, Peng G, Sahgal N, Fazli L, Gleave M, Zhang Y, Hussain A, Qi J. Fan L, et al. Among authors: fazli l. Oncogene. 2016 May 12;35(19):2441-52. doi: 10.1038/onc.2015.309. Epub 2015 Aug 17. Oncogene. 2016. PMID: 26279298 Free PMC article.

4

Targeting and killing of prostate cancer cells using lentiviral constructs containing a sequence recognized by translation factor eIF4E and a prostate-specific promoter.

Yu D, Scott C, Jia WW, De Benedetti A, Williams BJ, Fazli L, Wen Y, Gleave M, Nelson C, Rennie PS. Yu D, et al. Among authors: fazli l. Cancer Gene Ther. 2006 Jan 1;13(1):32-43. doi: 10.1038/sj.cgt.7700885. Cancer Gene Ther. 2006. PMID: 16052226

5

Lentiviruses with trastuzumab bound to their envelopes can target and kill prostate cancer cells.

Zhang KX, Moussavi M, Kim C, Chow E, Chen IS, Fazli L, Jia W, Rennie PS. Zhang KX, et al. Among authors: fazli l. Cancer Gene Ther. 2009 Nov;16(11):820-31. doi: 10.1038/cgt.2009.28. Epub 2009 Apr 17. Cancer Gene Ther. 2009. PMID: 19373278

6

Heat shock protein 27 confers resistance to androgen ablation and chemotherapy in prostate cancer cells through eIF4E.

Andrieu C, Taieb D, Baylot V, Ettinger S, Soubeyran P, De-Thonel A, Nelson C, Garrido C, So A, Fazli L, Bladou F, Gleave M, Iovanna JL, Rocchi P. Andrieu C, et al. Among authors: fazli l. Oncogene. 2010 Apr 1;29(13):1883-96. doi: 10.1038/onc.2009.479. Epub 2010 Jan 18. Oncogene. 2010. PMID: 20101233

7

Fibroblast growth factor and ornithine decarboxylase 5'UTRs enable preferential expression in human prostate cancer cells and in prostate tumors of PTEN(-/-) transgenic mice.

Moussavi M, Moshgabadi N, Fazli L, Leblanc E, Zhang K, Jia W, Rennie PS. Moussavi M, et al. Among authors: fazli l. Cancer Gene Ther. 2012 Jan;19(1):19-29. doi: 10.1038/cgt.2011.62. Epub 2011 Sep 16. Cancer Gene Ther. 2012. PMID: 21921943

8

DAB2IP loss confers the resistance of prostate cancer to androgen deprivation therapy through activating STAT3 and inhibiting apoptosis.

Zhou J, Ning Z, Wang B, Yun EJ, Zhang T, Pong RC, Fazli L, Gleave M, Zeng J, Fan J, Wang X, Li L, Hsieh JT, He D, Wu K. Zhou J, et al. Among authors: fazli l. Cell Death Dis. 2015 Oct 29;6(10):e1955. doi: 10.1038/cddis.2015.289. Cell Death Dis. 2015. PMID: 26512963 Free PMC article.

9

Quantification of large scale DNA organization for predicting prostate cancer recurrence.

MacAulay C, Keyes M, Hayes M, Lo A, Wang G, Guillaud M, Gleave M, Fazli L, Korbelik J, Collins C, Keyes S, Palcic B. MacAulay C, et al. Among authors: fazli l. Cytometry A. 2017 Dec;91(12):1164-1174. doi: 10.1002/cyto.a.23287. Epub 2017 Nov 30. Cytometry A. 2017. PMID: 29194951 Free article.

10

Prognostic value of Ki67 in localized prostate carcinoma: a multi-institutional study of >1000 prostatectomies.

Tretiakova MS, Wei W, Boyer HD, Newcomb LF, Hawley S, Auman H, Vakar-Lopez F, McKenney JK, Fazli L, Simko J, Troyer DA, Hurtado-Coll A, Thompson IM Jr, Carroll PR, Ellis WJ, Gleave ME, Nelson PS, Lin DW, True LD, Feng Z, Brooks JD. Tretiakova MS, et al. Among authors: fazli l. Prostate Cancer Prostatic Dis. 2016 Sep;19(3):264-70. doi: 10.1038/pcan.2016.12. Epub 2016 May 3. Prostate Cancer Prostatic Dis. 2016. PMID: 27136741 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

267 results

Search Page